| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.14 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |